Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

589
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
589
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

417
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
417
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

890
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
890
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

820
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
820
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

411
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
411
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

712
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
712

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes Following Fecal Diversion for Intractable Hirschsprung Associated Enterocolitis: A Study From the Pediatric Colorectal and Pelvic Learning Consortium.

Journal of pediatric surgery·2024
Same author

Variation in Practice Surrounding Antegrade Colonic Enema Channel Placement.

Journal of pediatric surgery·2024
Same author

Can Anorectal Stenosis be Managed With Dilations Alone? A PCPLC Review.

Journal of pediatric surgery·2024
Same author

Does Delayed Diagnosis of Hirschsprung Disease Impact Post-operative and Functional Outcomes? A Multi-Center Review From the Pediatric Colorectal and Pelvic Learning Consortium.

Journal of pediatric surgery·2024
Same author

Outcomes From Colonic Pull-Through for Cloacal Exstrophy Differ by Colon Length: A Multi-Institutional Study.

Journal of pediatric surgery·2023
Same author

Rectal Prolapse Following Repair of Anorectal Malformation: Incidence, Risk Factors, and Management.

Journal of pediatric surgery·2023

Related Experiment Video

Updated: Jan 4, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

351

Pediatric Inflammatory Bowel Disease: Special Considerations.

Megan K Fuller1

  • 1Department of Surgery, University of Nebraska Medical Center, Children's Hospital and Medical Center, Omaha, NE, USA; Boys Town National Research Hospital, Boystown, NE, USA.

The Surgical Clinics of North America
|November 3, 2019
PubMed
Summary

Pediatric inflammatory bowel disease (IBD) requires a broad differential diagnosis and lifelong treatment considerations. Key surgical triggers in children include growth impairment and steroid dependence, necessitating careful care transitions.

Keywords:
Pediatric Crohn’s diseasePediatric IBD–unclassifiedPediatric inflammatory bowel diseasePediatric ulcerative colitisVery early onset IBD (VEOIBD)

More Related Videos

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

780
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

3.0K

Related Experiment Videos

Last Updated: Jan 4, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

351
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

780
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

3.0K

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease (IBD) Research
  • Clinical Pediatrics

Background:

  • Pediatric inflammatory bowel disease (IBD) presents unique challenges compared to adult-onset disease.
  • Early-onset IBD necessitates a wider differential diagnosis to ensure accurate identification.
  • Long-term risks and benefits must guide diagnostic and treatment decisions throughout a patient's life.

Purpose of the Study:

  • To highlight the distinct presentation of pediatric IBD.
  • To emphasize the importance of a broad differential diagnosis in very early-onset IBD.
  • To underscore the need for lifelong risk-benefit analysis in managing pediatric IBD.

Main Methods:

  • Review of clinical presentations and diagnostic considerations in pediatric IBD.
  • Analysis of treatment strategies, including surgical triggers specific to children.
  • Evaluation of care transition protocols from pediatric to adult services.

Main Results:

  • Pediatric IBD may manifest differently than adult IBD, requiring expanded diagnostic considerations.
  • Impaired growth and steroid dependency are critical surgical indicators in children, alongside adult indications.
  • Successful transition to adult care is crucial for preventing disease flares and maintaining patient follow-up.

Conclusions:

  • Management of pediatric IBD demands a tailored approach considering lifelong implications.
  • Specific pediatric factors, such as growth and steroid use, influence surgical decision-making.
  • Optimized transition of care is essential for sustained IBD management and improved patient outcomes.